These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31645364)

  • 41. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Major depressive disorder treatment guidelines in America and Europe.
    Davidson JR
    J Clin Psychiatry; 2010; 71 Suppl E1():e04. PubMed ID: 20371031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial.
    Husain MI; Chaudhry IB; Rahman RR; Hamirani MM; Qurashi I; Khoso AB; Deakin JF; Husain N; Young AH
    Trials; 2015 Sep; 16():410. PubMed ID: 26374703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving adherence to antidepressants: a systematic review of interventions.
    Vergouwen AC; Bakker A; Katon WJ; Verheij TJ; Koerselman F
    J Clin Psychiatry; 2003 Dec; 64(12):1415-20. PubMed ID: 14728101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.
    Kessler RC; van Loo HM; Wardenaar KJ; Bossarte RM; Brenner LA; Ebert DD; de Jonge P; Nierenberg AA; Rosellini AJ; Sampson NA; Schoevers RA; Wilcox MA; Zaslavsky AM
    Epidemiol Psychiatr Sci; 2017 Feb; 26(1):22-36. PubMed ID: 26810628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
    Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011565. PubMed ID: 26968204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis.
    Shinohara K; Efthimiou O; Ostinelli EG; Tomlinson A; Geddes JR; Nierenberg AA; Ruhe HG; Furukawa TA; Cipriani A
    BMJ Open; 2019 May; 9(5):e027574. PubMed ID: 31110100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. International consensus statement on major depressive disorder.
    Nutt DJ; Davidson JR; Gelenberg AJ; Higuchi T; Kanba S; Karamustafalioğlu O; Papakostas GI; Sakamoto K; Terao T; Zhang M
    J Clin Psychiatry; 2010; 71 Suppl E1():e08. PubMed ID: 20371035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Precision psychiatry in clinical practice.
    Zanardi R; Prestifilippo D; Fabbri C; Colombo C; Maron E; Serretti A
    Int J Psychiatry Clin Pract; 2021 Mar; 25(1):19-27. PubMed ID: 32852246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophrenia.
    Korchia T; Tastevin M; Sunhary de Verville PL; Joober R; Andrieu-Haller C; Faugere M; Godin O; Etchecopar-Etchart D; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Dubreucq J; Mallet J; Misdrahi D; Passerieux C; Rey R; Schürhoff F; Szoke A; Urbach M; Leboyer M; Llorca PM; Lançon C; Richieri R; Boyer L; Fond G
    World J Biol Psychiatry; 2022 Nov; 23(9):703-714. PubMed ID: 35057713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression.
    Jones C; Nemeroff CB
    Adv Exp Med Biol; 2021; 1305():535-563. PubMed ID: 33834417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting treatment effects in unipolar depression: A meta-review.
    Gillett G; Tomlinson A; Efthimiou O; Cipriani A
    Pharmacol Ther; 2020 Aug; 212():107557. PubMed ID: 32437828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moving toward a process-oriented perspective in the personalized treatment of depression.
    Kopf-Beck J; Fietz J
    Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):413-415. PubMed ID: 33666694
    [No Abstract]   [Full Text] [Related]  

  • 55. Can precision medicine advance psychiatry?
    Roche D; Russell V
    Ir J Psychol Med; 2021 Sep; 38(3):163-168. PubMed ID: 32677603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting treatment outcome in depression: an introduction into current concepts and challenges.
    Rost N; Binder EB; Brückl TM
    Eur Arch Psychiatry Clin Neurosci; 2023 Feb; 273(1):113-127. PubMed ID: 35587279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.
    Zhou X; Teng T; Zhang Y; Del Giovane C; Furukawa TA; Weisz JR; Li X; Cuijpers P; Coghill D; Xiang Y; Hetrick SE; Leucht S; Qin M; Barth J; Ravindran AV; Yang L; Curry J; Fan L; Silva SG; Cipriani A; Xie P
    Lancet Psychiatry; 2020 Jul; 7(7):581-601. PubMed ID: 32563306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder.
    Kryst J; Kawalec P; Pilc A
    Expert Opin Pharmacother; 2020 Jan; 21(1):9-20. PubMed ID: 31663783
    [No Abstract]   [Full Text] [Related]  

  • 59. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.
    Maslej MM; Furukawa TA; Cipriani A; Andrews PW; Sanches M; Tomlinson A; Volkmann C; McCutcheon RA; Howes O; Guo X; Mulsant BH
    JAMA Psychiatry; 2021 May; 78(5):490-497. PubMed ID: 33595620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review and Consensus on Pharmacogenomic Testing in Psychiatry.
    Bousman CA; Bengesser SA; Aitchison KJ; Amare AT; Aschauer H; Baune BT; Asl BB; Bishop JR; Burmeister M; Chaumette B; Chen LS; Cordner ZA; Deckert J; Degenhardt F; DeLisi LE; Folkersen L; Kennedy JL; Klein TE; McClay JL; McMahon FJ; Musil R; Saccone NL; Sangkuhl K; Stowe RM; Tan EC; Tiwari AK; Zai CC; Zai G; Zhang J; Gaedigk A; Müller DJ
    Pharmacopsychiatry; 2021 Jan; 54(1):5-17. PubMed ID: 33147643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.